Search
Search Results
-
Identification of Plasma Metabolites Associated with Lung Cancer Survival
Limited knowledge has been reported regarding the performance of plasma metabolomics for predicting lung cancer prognosis. In this chapter, we...
-
Interaction analysis of high-risk pathological features on adjuvant chemotherapy survival benefit in stage II colon cancer patients: a multi-center, retrospective study
BackgroundWe aimed to analyze the benefit of adjuvant chemotherapy in high-risk stage II colon cancer patients and the impact of high-risk factors on...
-
PIK3CA mutation status, progression and survival in advanced HR + /HER2- breast cancer: a meta-analysis of published clinical trials
BackgroundApproximately 40% of hormone receptor positive/human epidermal receptor 2 negative (HR + /HER2-) metastatic breast cancer (mBC) patients...
-
Conditional survival in multiple myeloma and impact of prognostic factors over time
Overall survival estimates from diagnosis are valuable for guiding treatment, but do not consider the years already survived. Conditional survival...
-
Survival outcomes of esophageal cancer patients with recurrence after curative treatments
BackgroundLittle is known about predictive factors for survival outcomes of esophageal carcinoma (EC) patients who developed recurrence after...
-
Overall survival of patients with thyroid cancer in Martinique (2008–2018)
BackgroundThyroid cancer (TC) overall survival at 5 years was estimated at 97% in mainland France over 2010–2015. Its prognosis is known to be...
-
Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer
BackgroundDespite some therapeutic advances, improvement in survival rates of unresectable and/or metastatic pancreatic ductal adenocarcinoma (PDAC)...
-
Long-term survival in venous thromboembolic disease: rivaroxaban vs. warfarin – propensity score matching study
BackgroundVenous thromboembolic disease (VTE) is characterized by obstruction of venous blood flow by a thrombus. Survival data, frequency of disease...
-
Adult head and neck rhabdomyosarcoma: radiotherapy- based treatment, outcomes, and predictors of survival
BackgroundAdult head and neck rhabdomyosarcoma (HNRMS) is an exceptionally rare malignancy, and there is a paucity of data and research dedicated to...
-
Primary central nervous system lymphoma high incidence and poor survival in Finnish population-based analysis
BackgroundWe report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland.
...
-
A novel necroptosis signature for predicting survival in lung adenocarcinoma
BackgroundTo explore the necroptosis-related genes (NRGs) signature and its predictive values in lung adenocarcinoma (LUAD).
MethodsThe training...
-
Racial and socioeconomic disparities in survival improvement of eight cancers
BackgroundMany studies have characterized racial differences in cancer outcomes, demonstrating that black and Hispanic patients have lower...
-
Recurrence and survival of patients with stage III endometrial cancer after radical surgery followed by adjuvant chemo- or chemoradiotherapy: a systematic review and meta-analysis
ObjectiveTo compare recurrence and survival in patients with stage III endometrial cancer after radical surgery, followed by either adjuvant...
-
Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer
As the dominant component of the tumor microenvironment, cancer-associated fibroblasts (CAFs), play a vital role in tumor progression. An increasing...
-
Body composition and cancer survival: a narrative review
Interest in understanding the relationship between body composition and cancer survival has remained strong for decades, with a number of recent...
-
Clinicopathological features of HER2 positive metastatic colorectal cancer and survival analysis of anti-HER2 treatment
BackgroundWe aimed to investigate response and prognostic factors in patients with human epidermal growth factor receptor 2 (HER2) positive...
-
Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer—exploratory analysis of LATITUDE study
BackgroundPain is an important dimension of quality-of-life in patients with metastatic castrate-sensitive prostate cancer (mCSPC). However, it is...
-
Clinical characteristics and survival analysis of Chinese ovarian cancer patients with RAD51D germline mutations
ObjectivesWe aimed to describe the behavior among Chinese ovarian cancer patients with RAD51D germline mutations at our institution.
Methods ...
-
Receptor conversion and survival in breast cancer liver metastases
BackgroundBreast cancer liver metastases (BCLM) is a common cause of breast cancer-related death. The prognostic and predictive value of receptor...
-
Identification on surrogating overall survival with progression-free survival of first-line immunochemotherapy in advanced esophageal squamous cell carcinoma—an exploration of surrogate endpoint
BackgroundOverall survival (OS) is the gold standard to assess novel therapeutics to treat cancer. However, to identify early efficacy and speed up...
